Esperion Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Great. Good morning, everyone. My name is Jess Fye. I'm one of the biotech analysts at JPMorgan. And we're continuing the 2020 conference today with Esperion.
Quick housekeeping note. Since we're coming up on lunchtime, the breakout session for this company is going to be at 1:30 in the Elizabethan C room, so right next door. So come back at 1:30 if you want to hear Q&A with management.
But for the presentation, I'll pass it over to the company's CEO, Tim Mayleben.
I was waiting for some applause. No. I'm kidding. Thank you, Jess, for the opportunity to be with you here this morning. This is a really transformative year for our company. And so I'm especially pleased to be here with you.
If you remember anything today, I'd like you to remember 3 things: First of all, something we've been saying quite consistently now, we're here in the beginning of 2020. When I started in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
